Moreover, the higher expression of iNOS in ovarian cancer specimens can predict poor prognosis, supporting the idea of the iNOS as a helpful prognostic marker and a potential therapeutic target for ovary cancer. Here, NOS2 is linked to ovarian carcinoma.